0001209191-20-056817.txt : 20201103 0001209191-20-056817.hdr.sgml : 20201103 20201103212305 ACCESSION NUMBER: 0001209191-20-056817 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201030 FILED AS OF DATE: 20201103 DATE AS OF CHANGE: 20201103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kronfol Amr CENTRAL INDEX KEY: 0001731772 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39160 FILM NUMBER: 201285041 MAIL ADDRESS: STREET 1: C/O WARBURG PINCUS LLC STREET 2: 450 LEXINGTON AVE CITY: NEW YORK STATE: NY ZIP: 10017 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SOC Telemed, Inc. CENTRAL INDEX KEY: 0001791091 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] IRS NUMBER: 843131208 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1768 BUSINESS CENTER DRIVE STREET 2: SUITE 100 CITY: RESTON STATE: VA ZIP: 20190 BUSINESS PHONE: 866-483-9690 MAIL ADDRESS: STREET 1: 1768 BUSINESS CENTER DRIVE STREET 2: SUITE 100 CITY: RESTON STATE: VA ZIP: 20190 FORMER COMPANY: FORMER CONFORMED NAME: Healthcare Merger Corp. DATE OF NAME CHANGE: 20191015 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-10-30 0 0001791091 SOC Telemed, Inc. TLMD 0001731772 Kronfol Amr C/O SOC TELEMED, INC. 1768 BUSINESS CENTER DRIVE, SUITE 100 RESTON VA 20190 1 0 0 0 Common Stock 2020-10-30 4 A 0 33311 A 33311 D Common Stock 2020-10-30 4 A 0 9628 A 42939 D Stock Options 2.48 2020-10-30 4 A 0 11039 A 2026-04-26 Common Stock 11039 11039 D Stock Options 4.95 2020-10-30 4 A 0 4730 A 2026-04-26 Common Stock 4730 4730 D Stock Options 2.48 2020-10-30 4 A 0 18398 A 2026-04-26 Common Stock 18398 18398 D Stock Options 4.95 2020-10-30 4 A 0 7885 A 2026-04-26 Common Stock 7885 7885 D Received in connection with the Issuer's business combination (the "Business Combination") with Specialists On Call, Inc. ("Legacy SOC Telemed") in accordance with the terms of the Agreement and Plan of Merger dated as of July 29, 2020, among the Issuer (f/k/a Healthcare Merger Corp.), Sabre Merger Sub I, Inc., Sabre Merger Sub II, LLC and Legacy SOC Telemed, in exchange for options to acquire 109,124 shares of common stock of Legacy SOC Telemed for $1.00 per share. Received in connection with the Business Combination in exchange for options to acquire 46,768 shares of common stock of Legacy SOC Telemed for $2.00 per share. The stock option vested and became exercisable as to 1/5th of the total number of shares on April 26, 2017 and thereafter vested and will continue to vest and become exercisable as to 1/5th of the total number of shares in equal annual installments, subject to the continuous service of the Reporting Person on each vesting date. Received in connection with the Business Combination in exchange for options to acquire 27,281 shares of common stock of Legacy SOC Telemed for $1.00 per share. Received in connection with the Business Combination in exchange for options to acquire 11,691 shares of common stock of Legacy SOC Telemed for $2.00 per share. The stock option will vest and become exercisable in full in the event of a change in control of the Issuer, subject to the continuous service of the Reporting Person on such vesting date. Received in connection with the Business Combination in exchange for options to acquire 45,468 shares of common stock of Legacy SOC Telemed for $1.00 per share. Received in connection with the Business Combination in exchange for options to acquire 19,486 shares of common stock of Legacy SOC Telemed for $2.00 per share. /s/ Eunice Kim, as Attorney-in-Fact 2020-11-03